New Drugs and Interventional Strategies for the Management of Hypertension

Author(s): Theodoros Christophides*, Alberto Somaschini*, Andrea Demarchi, Stefano Cornara, Maria Androulaki, Emmanuel Androulakis

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 11 , 2021

Become EABM
Become Reviewer
Call for Editor


Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.

Keywords: Hypertension, therapy, drug, intervention, novel, blood pressure.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 05 November, 2020
Page: [1396 - 1406]
Pages: 11
DOI: 10.2174/1381612826666201106091527
Price: $65

Article Metrics

PDF: 142